Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

This repository is under review for potential modification in compliance with Administration directives.

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

US Approved Allergenic Extract

19

Other

1

Possibly Marketed Outside US

1

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

NF-kappa B signaling pathway

19

cell cycle G2/M phase transition

19

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

19

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1994

19

2013

1

Unknown

1

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Eczema

19

Unknown

19

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Primary

19

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Penetrant

19

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Cronstedt, A.F.

19

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

21

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

21

FDA UNII

21

PUBCHEM

21

EPA CompTox

19

SMS_ID

17

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Salts, Hydrates, Esters, etc.

18

Principal Form

3

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 10 of 21 results

First page disabled
Previous page disabled
1
Next page
Next page

CYCLOHEXENE

12L0P8F7GN

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

NICKEL CATION

OIS2CXW7AM

Export Data
Search for Structure

Status:

US Approved Allergenic Extract (1994)

First approved in 1994

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

NF-kappa B signaling pathway

cell cycle G2/M phase transition

Conditions:

Nickel (II) oxide is an olive gray powder, insoluble in water and soluble in acids. It is produced industrially and used mainly as an intermediate in the production of nickel alloys and as a hydrogenation catalyst. Long-term inhalation of NiO is dama...

ging to the lungs, causing lesions and in some cases cancer.

1-DODECENE

WYE669F3GR

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 2013

Class (Stereo):

CHEMICAL (ACHIRAL)

NICKEL PERCHLORATE

BQ8A24MEZO

Export Data
Search for Structure

Status:

US Approved Allergenic Extract (1994)

First approved in 1994

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

NF-kappa B signaling pathway

cell cycle G2/M phase transition

Conditions:

Nickel (II) oxide is an olive gray powder, insoluble in water and soluble in acids. It is produced industrially and used mainly as an intermediate in the production of nickel alloys and as a hydrogenation catalyst. Long-term inhalation of NiO is dama...

ging to the lungs, causing lesions and in some cases cancer.

NICKEL FORMATE

Y4YT27N8QN

Export Data
Search for Structure

Status:

US Approved Allergenic Extract (1994)

First approved in 1994

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

NF-kappa B signaling pathway

cell cycle G2/M phase transition

Conditions:

Nickel (II) oxide is an olive gray powder, insoluble in water and soluble in acids. It is produced industrially and used mainly as an intermediate in the production of nickel alloys and as a hydrogenation catalyst. Long-term inhalation of NiO is dama...

ging to the lungs, causing lesions and in some cases cancer.

NICKEL FLUORIDE

69NBB20493

Export Data
Search for Structure

Status:

US Approved Allergenic Extract (1994)

First approved in 1994

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

NF-kappa B signaling pathway

cell cycle G2/M phase transition

Conditions:

Nickel (II) oxide is an olive gray powder, insoluble in water and soluble in acids. It is produced industrially and used mainly as an intermediate in the production of nickel alloys and as a hydrogenation catalyst. Long-term inhalation of NiO is dama...

ging to the lungs, causing lesions and in some cases cancer.

NICKEL CHLORIDE

696BNE976J

Export Data
Search for Structure

Status:

US Approved Allergenic Extract (1994)

First approved in 1994

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

NF-kappa B signaling pathway

cell cycle G2/M phase transition

Conditions:

Nickel (II) oxide is an olive gray powder, insoluble in water and soluble in acids. It is produced industrially and used mainly as an intermediate in the production of nickel alloys and as a hydrogenation catalyst. Long-term inhalation of NiO is dama...

ging to the lungs, causing lesions and in some cases cancer.

NICKEL AMMONIUM SULFATE HEXAHYDRATE

Q5LM426K64

Export Data
Search for Structure

Status:

US Approved Allergenic Extract (1994)

First approved in 1994

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

NF-kappa B signaling pathway

cell cycle G2/M phase transition

Conditions:

Nickel (II) oxide is an olive gray powder, insoluble in water and soluble in acids. It is produced industrially and used mainly as an intermediate in the production of nickel alloys and as a hydrogenation catalyst. Long-term inhalation of NiO is dama...

ging to the lungs, causing lesions and in some cases cancer.

NICKEL GLUCONATE

2EQ06R5QSQ

Export Data
Search for Structure

Status:

US Approved Allergenic Extract (1994)

First approved in 1994

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

NF-kappa B signaling pathway

cell cycle G2/M phase transition

Conditions:

Nickel (II) oxide is an olive gray powder, insoluble in water and soluble in acids. It is produced industrially and used mainly as an intermediate in the production of nickel alloys and as a hydrogenation catalyst. Long-term inhalation of NiO is dama...

ging to the lungs, causing lesions and in some cases cancer.

NICKEL CARBONATE

WM50SQU829

Export Data
Search for Structure

Status:

US Approved Allergenic Extract (1994)

First approved in 1994

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

NF-kappa B signaling pathway

cell cycle G2/M phase transition

Conditions:

Nickel (II) oxide is an olive gray powder, insoluble in water and soluble in acids. It is produced industrially and used mainly as an intermediate in the production of nickel alloys and as a hydrogenation catalyst. Long-term inhalation of NiO is dama...

ging to the lungs, causing lesions and in some cases cancer.

Showing 1 - 10 of 21 results

First page disabled
Previous page disabled
1
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1